Similar Posts
New Review of FBI’s Work in Anthrax Letters Case/ WSJ
New Review of FBI’s Work in Anthrax Letters Case By Devlin Barrett, Wall Street Journal The investigative arm of Congress will take another look at the science the FBI used to determine who mailed deadly anthrax-laced letters in 2001. The Government Accountability Office has notified Rep. Rush Holt, a New Jersey Democrat, that the agency…
Pfizer and FDA reveal Paxlovid fails clinical trial, as FDA tries to evade its responsibility by emphasizing the drug is not approved, not even for COVID
Suddenly Pfizer’s website and the FDA want to emphasize all the problems with Paxlovid. So in the case of this drug, these two co-conspirators apparently think that disclosures will save them from something. Just look at this language! Compare to the lack of disclosure of adverse effects long known to be due to the COVID…
The Mask Debacle: How partisan warfare over mandates became a central feature of the pandemic/Tablet
https://www.tabletmag.com/sections/science/articles/the-mask-debacle Recent days have witnessed the emergence of a new rift in our pandemic debate. Strikingly, this time the dispute is not just partisan, but also splitting the Democratic Party. While Democratic governors appear to see where political winds are blowing, some blue cities are moving in the opposite direction. And many states that are dropping adult mask mandates are retaining them for kids,…
A long-term perspective on immunity to COVID/ Nature
https://www.nature.com/articles/d41586-021-01557-z nature news & views article NEWS AND VIEWS 14 June 2021 A long-term perspective on immunity to COVID Determining the duration of protective immunity to infection by SARS-CoV-2 is crucial for understanding and predicting the course of the COVID-19 pandemic. Clinical studies now indicate that immunity will be long-lasting. “The good news is that…
FDA approves a booster for kids as young as age 5, since their vaccine no longer works and may actually encourage infection
FDA gave the booster (3d dose) for elementary school children its blessing today. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-expands-eligibility-pfizer-biontech-covid-19-vaccine-booster-dose “On Jan. 3, the FDA authorized the use of a single booster dose of the Pfizer-BioNTech COVID-19 Vaccine for administration to individuals 12 through 15 years of age after completion of primary vaccination with the Pfizer-BioNTech COVID-19 Vaccine. Today’s action…
Get the infection, take the medicine, get over it and get durable immunity to variants. Not so for the poor vaccinated population, whose immunity against variants is poor/ Cell journal
https://www.cell.com/cell/fulltext/S0092-8674(21)00298-1 Highlights Numerous variants of SARS-CoV-2 harboring mutations in spike have arisen globally mRNA vaccines elicit potent neutralizing activity against homologous pseudovirus Cross-neutralization of strains with receptor binding domain (RBD) mutations is poor Both RBD and non-RBD mutations mediate escape from vaccine-induced humoral immunity Summary Vaccination elicits immune responses capable of potently neutralizing SARS-CoV-2. However,…